动物卫生市场规模,分享与趋势乐鱼体育手机网站入口分析Report By Animal Type (Production, Companion), By End Use, By Product (Pharmaceuticals, Feed Additives, Vaccines), By Distribution Channel, By Region, And Segment Forecasts, 2022 - 2030

Report Overview

全球动物头脑lth market size was valued at USD 39.9 billion in 2021 and is expected to witness a compound annual growth rate (CAGR) of 10.0% from 2022 to 2030. The market is largely driven by a significant rise in demand for protein food and an increase in the incidence of zoonotic and food-borne diseases globally. This unprecedented rise in disease prevalence has triggered companies to produce advanced vaccines and pharmaceuticals. The high demand has also resulted in a subsequent increase in the number of companies undertaking consistent efforts to control pathogen contamination risks and food-borne diseases, which is contributing to market growth. In addition, the rising number of government initiatives to promote animal health products is presumed to drive the overall market.

In spite of disruption due to the COVID-19 pandemic, the animal health industry witnessed steady growth. The trend fortelemedicinehas witnessed significant growth during the pandemic. Online channels such aseCommerceare the most preferred distribution channels by pet owners for purchasing vet products andpet food. According to the UN Department of Economic and Social Affairs, the global population is approximately 7.3 billion and it is anticipated to reach around 9.7 billion by 2050; of which, 795 million people are undernourished, as per the estimations of the International Fund for Agricultural Development (IFAD). The aforementioned statistics exemplify the urgent requirement to expand the food supply through large-scale adoption of livestock.

The heightened production of animal-based food products will lead to a significant price reduction, facilitating easy access to food at affordable prices. The market for animal health is also driven by technological advancements in veterinary health care, and this is anticipated to offer future growth opportunities. These advancements include the advent of efficient information management systems, animal owner mobile technology, and vaccine banks. Growing focus on innovation in animal health has given rise to certain measures that are strengthening market growth prospects. For instance, the Innovative Medicines Initiative (IMI) is a public-private partnership to support collaborative research to boost innovation in veterinary pharmaceuticals in Europe.

Animal Health Market: The market growth remains steady despite supply chain disruptions caused by the pandemic

Pandemic Impact	Post COVID Outlook
Despite disruption due to the COVID-19 pandemic, the animal health industry witnessed a steady growth of 8% from 2019 to 2020. The economic downturn is relatively lower in the animal health market as compared to others	There will be a shift in business models for veterinarians. Traditional veterinary practices generate a majority of their revenues from selling high-margin products like pharmaceuticals. However, as the adoption of telehealth has been on the rise, the demand for knowledge, expertise, and consulting solutions will increase
The trend for telemedicine has witnessed significant growth during the pandemic. Online channels, such as eCommerce, are the most preferred distribution channels by pet owners for purchasing vet products & pet food. The E-Commerce segment witnessed a lucrative growth rate of 10.7%	Animal healthcare is rebounding faster as compared to other sectors. Large-scale animal health companies are focusing on innovative strategies to gain a competitive edge
Major players operating in the market witnessed growth during the pandemic despite the restriction & supply chain disruption. IDEXX reported a 12% increase in year-on-year revenue, driven by the Companion Animal Group (CAG) diagnostics segment in December 2020	Consolidation will continue in the market. For instance, Merck Animal Health completed the acquisition of Poultry Sense Ltd. in February 2021 to expand its vertical in the poultry business and have technology in health & environmental monitoring solutions
By Q3 2020, Elanco's revenue improved by 15%, compared to Q3 2019, with a notable recovery in the pet health industry. However, unfavorable macroeconomic conditions and reduced consumption trends continued to affect Elanco's international livestock business

The economic downturn is relatively lower in animal health as compared to others. There will be a shift in business models for veterinarians in post-pandemic situations. Traditional veterinary practices generate the majority of their revenues from selling high-margin products like pharmaceuticals. However, as the adoption oftelehealthhas been on rising the demand for knowledge, expertise and consulting solutions will increase.

Product Insights

The pharmaceutical segment dominated the market for animal health and held the largest revenue share of over 33.7% in 2021. It is estimated to retain its dominant position throughout the forecast period on account of consistent advancements in veterinary drugs. Pharmaceuticals primarily include anti-inflammatory drugs, parasiticides,antibiotics, and others. It is also believed that a considerable increase in companion animal ownership has also expedited the adoption of pharmaceuticals to help increase longevity. Moreover, an increasing number of mergers and acquisitions, for instance, the acquisition of Bayer by Elanco has resulted in the multimarket distribution of their products, including pharmaceuticals. Mergers and acquisitions are considered one of the key factors contributing to segment growth over the years.

兽医诊断段预计witness significant growth over the forecast period. Various factors such as growing animal health expenditure, rising incidence of zoonotic diseases, and increasing number of veterinary practitioners and their incomes in developed economies are also responsible for market growth. Companies are investing in the expansion of their manufacturing facilities, which is expected to positively influence the market for animal health over the forecast period. There has been an increase in the demand for point-of-care diagnostics, such as blood glucose monitors, pregnancy kits, and urinalysis strips, by pet owners. Food animal diagnostics remain confined to labs due to high sensitivity and efficacy requirements in disease testing.

The others segment is expected to witness the fastest CAGR of 16.1% from 2022 to 2030. This segment is inclusive of the other vet care products and services such as grooming,veterinary telehealth,veterinary software,livestock monitoring, and others. Growing R&D activities for the development of better and more efficient products are anticipated to boost the market for animal health. Besides, market growth is driven by the growing prevalence of diseases among companion animals, increasing focus on animal health among pet owners, growing animal health expenditure, increasing population of companion animals, rising demand for pet insurance, and the increasing number of the veterinary surgeon and income levels in developed economies.

Animal Type Insights

The production animal segment dominated the market for animal health and accounted for the largest revenue share of over 64.0% in 2021. The substantial share captured by the segment can be presumed a consequence of high concern for food safety and sustainability by government healthcare organizations globally. Policymakers in various countries are striving to achieve total food security, which propels large-scale food production and results in greater rearing of livestock. The policies are focused on long-term sustainability, which can be achieved through a combination of improving productivity and greater attention to livestock veterinary healthcare.

According to Food and Agriculture Organization, in the emerging economies, animal-based food products account for one-third of human protein consumption, leading to an increase in livestock productivity, which is critical to meet the dietary needs of the growing human population. These factors cumulatively are responsible for the significant share captured by production animals in this segment. The companion animal segment is expected to grow lucratively during the forecast period owing to an increase in demand for efficient animal care and the pet-human bond due to the associated health benefits. Companion animals are known to lower blood pressure, provide psychological stability, and reduce the frequency of cardiac arrhythmias and anxiety attacks, which enhance the overall well-being of humans. Consequentially, animal-assisted therapy is increasingly preferred as a result of these companion animal products, which, in turn, is likely to drive the segment in the coming years.

Distribution Channel Insights

The veterinary hospital pharmacy segment accounted for a revenue share of over 51.0% in 2021. The increasing number of hospital pharmacies, coupled with high procedural volume as a consequence of frequent readmission of pets for treatment, has supported segment growth. Retail channels and e-commerce platforms also accounted for a significant share of the total market. The e-commerce segment is anticipated to witness exponential growth throughout the forecast period. This can be attributed to various advantages such as increased convenience for patients not willing to purchase medicines from retail or hospital pharmacies.

Moreover, these also facilitate a consistent supply of drugs, as medications can be preordered. Benefits such as these are anticipated to accentuate the demand for e-commerce throughout the forecast period. With the help of online pharmacies, order procurement and tracking become easy as associated Supply Chain Management (SCM) eliminates other market intermediaries of the delivery channel. This reduces overall costs, thereby increasing customer preference. Retail pharmacies for animal health products are expected to grow at a moderate rate throughout the forecast period.

Major manufacturers rely on only licensed veterinarians and authorized distributors for the distribution of medications andvaccines. This is anticipated to propel segment growth over the forecast period. E-commerce/online pharmacies selling animal health products are anticipated to witness exponential growth throughout the forecast period. This growth is believed to be a result of various advantages such as increased convenience for patients not willing to purchase medicines from retail or hospital pharmacies.

End-use Insights

The veterinary hospitals and clinics segment accounted for the largest revenue share of over 73.0% in 2021. The dominant share captured by this segment is a consequence of various applications such as clinical pathology, toxicology tests, and therapy. The availability of a wide range of treatment as well as diagnostic options in veterinary hospitals and clinics is a high-impact rendering growth driver for this segment. An increase in the incidence of zoonotic diseases caused by globalization and climate changes is expected to drive the demand for diagnostic procedures, which is expected to drive the point-of-care testing/in-house testing segment in the coming years.

The increase in initiatives to create awareness among companion animal owners about the benefits and value of preventive care in pets is one of the key contributing factors to in-house testing in animal health. Tests such as ELISA have been proven an effective point-of-care tests for heartworm diagnosis. Certain vaccines are only available in accredited veterinary hospitals and clinics, which is responsible for increasing the share of this end-user segment. Various government animal welfare organizations have issued guidelines for safety practices and standards to be implemented in veterinary hospitals and clinics, which has broadened the scope for segment growth over the past few years.

Regional Insights

North America dominated the market for animal health and accounted for the largest revenue share of 29.5% in 2021, owing to the wide range of definitive measures adopted by government animal welfare organizations that are consistently working for overall improvement in animal health. Furthermore, technological advancements, the rising incidence of zoonotic diseases, and an increasing number of pet owners are expected to boost the market growth in this country. Several collaborative efforts by major companies to enhance their R&D capabilities and ensure high-quality standards are anticipated to impel the demand further across this region. Moreover, the majority share can also be attributed to the high disease burden in this region.

In Asia Pacific, the market for animal health is expected to register a lucrative CAGR of 10.5% over the coming years. The high growth registered by this region is believed to be a consequence of consistent R&D investments by prominent players in the field of animal health and their efforts to commercialize branded and generic therapeutics at a relatively inexpensive price. The exponential growth is owing to growing awareness pertaining to pet nutrition and supplies and increasing disposable income.

Key Companies & Market Share Insights

Major players operating in the market witnessed growth during the pandemic in spite of the restriction and supply chain disruption. IDEXX, reported a 12% increase in year-on-year revenue, driven by the Companion Animal Group (CAG) diagnostics segment. Consolidation will continue in the animal health market. For instance, Merck Animal Health completes the acquisition of Poultry Sense Ltd in February 2021 to expand its vertical in the poultry business and have technology in health and environmental monitoring solutions. The registered growth in the market for animal health is a result of product launches, extensive regional expansion strategies, mergers and acquisitions, and collaborative research initiatives undertaken by major market players.

For instance, in August 2021, Elanco closed the acquisition of Kindred Biosciences. With this acquisition, Elanco strengthened and accelerated its innovation, portfolio, and productivity (IPP) strategy, and positioned itself to bring solutions for veterinarians and animal owners in areas of under-served or unmet medical needs. In April 2021, Hester Biosciences launched a range of herbal veterinary products. Likewise, in July 2020, Merck Animal Health ramped up its animal vaccine production capacity with a USD 100 million investment in its Kansas manufacturing site. These types of initiatives are anticipated to fuel market growth in the coming years. Some prominent players in the global animal health market include:

• Merck Animal Health

• Ceva Sante Animale

• Vetoquinol S.A.

• Zoetis

• Boehringer Ingelheim GmbH

• Elanco

• IDEXX

• Heska Corporation

• Covetrus

• DRE Veterinary

• Mars Inc.

• Virbac

• Televet

• Phibro Animal Health Corporation

• Vetoquinol S.A

• B. Braun Vet Care

Animal Health Market Report Scope

Report Attribute	Details
The market size value in 2022	USD 43.3 Billion
The revenue forecast in 2030	USD 92.8 Billion
Growth Rate	CAGR of 10.0% from 2022 to 2030
Base year for estimation	2021
Actual estimates/Historical data	2017 - 2020
Forecast period	2022 - 2030
Quantitative units	Revenue in USD Million & CAGR from 2022 to 2030
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Animal Type, product, distribution channel, end use, region
Country Scope	U.S.; Canada; Germany; U.K.; France; Italy; Russia; Spain; Netherlands; Switzerland; Sweden; Ireland; Poland; Japan; China; India; Indonesia; Thailand; Australia; South Korea; Philippines; Malaysia; Singapore; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; Turkey; Iran; United Arab Emirates; Israel
Key companies profiled	Merck Animal Health, Ceva Sante Animale, Vetoquinol S.A., Zoetis, Boehringer Ingelheim GmbH, Elanco, IDEXX, Heska Corporation, Covetrus, DRE Veterinary, Mars Inc., Virbac, Televet, Phibro Animal Health Corporation, B.Braun Vet Care
Customization scope	Free report customization (equivalent up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs.Explore purchase options

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For the purpose of this study, Grand View Research has segmented the global animal health market report on the basis of animal type, product, distribution channel, end use, and region:

• Animal Type Outlook (Revenue, USD Million, 2017 - 2030)

  • Production Animal

    • Poultry

    • Swine

    • Cattle

    • Sheep & Goats

    • Fish

  • Companion Animal

    • Dogs

    • Cats

    • Horses

    • Others

• Product Outlook (Revenue, USD Million, 2017 - 2030)

  • Vaccines

    • Live Attenuated Vaccines

    • DNA Vaccines

    • Recombinant Vaccines

    • Inactivated Vaccines

    • Others

  • Pharmaceuticals

    • Parasiticides

    • Anti-infective

    • Anti-inflammatory

    • Analgesics

    • Others

  • Medicinal Feed Additives

  • Diagnostics

    • Instruments

    • Consumables

  • Equipment & Disposables

    • Critical Care Consumables

    • Anesthesia Equipment

    • Fluid Management Equipment

    • Temperature Management Equipment

    • Rescue & Resuscitation Equipment

    • Research Equipment

    • Patient Monitoring Equipment

  • Others

    • Veterinary Telehealth

    • Veterinary Software

    • Livestock Monitoring

• Distribution Channel Outlook (Revenue, USD Million, 2017 - 2030)

  • Retail

  • E-commerce

  • Veterinary Hospitals & Clinics

• 最终用途前景(收入,百万美元,2017 - 2030)

  • Reference Laboratories

  • Point-of-care Testing/In-house Testing

  • Veterinary Hospitals & Clinics

  • Others

• Regional Outlook (Revenue, USD Million, 2017 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Russia

    • Spain

    • Netherlands

    • Switzerland

    • Sweden

    • Ireland

    • Poland

  • Asia Pacific

    • Japan

    • China

    • India

    • Indonesia

    • Thailand

    • Australia

    • South Korea

    • Philippines

    • Malaysia

    • Singapore

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • Turkey

    • Iran

    • United Arab Emirates

    • Israel